Investors.karyopharm.com

  1. Home
  2. Investors.karyopharm.com

Karyopharm Announces Expansion Of Royalty Agreement With …

WEBNEWTON, Mass., June 24, 2021 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer …

Actived: 1 days ago

URL: https://investors.karyopharm.com/2021-06-24-Karyopharm-Announces-Expansion-Of-Royalty-Agreement-With-Healthcare-Royalty-For-Up-To-100-Million

Investor Relations Karyopharm Therapeutics

WEBKaryopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029. – …

Category:  Health Go Health

Publications and Presentations

WEBPublished data and presentations from medical conferences for Karyopharm’s investigational drug candidates. This page is intended to provide scientific information to …

Category:  Medical Go Health

Karyopharm and Menarini Group Receive Positive CHMP Opinion …

WEB̶ European Commission Decision Anticipated within Approximately 60 Days – NEWTON, Mass. and FLORENCE, Italy, May 20, 2022 /PRNewswire/ -- Karyopharm …

Category:  Health Go Health

Privacy Preference Center

WEBNEWTON, Mass., Feb. 8, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, …

Category:  Cancer Go Health

Karyopharm Names New Head of Investor Relations

WEBNEWTON, Mass., March 14, 2022 / PRNewswire / -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer …

Category:  Cancer Go Health

Privacy Preference Center

WEB– Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication – – Approval Follows Positive Opinion by …

Category:  Health Go Health

Privacy Preference Center

WEBNEWTON, Mass., March 1, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer …

Category:  Cancer Go Health

Privacy Preference Center

WEBNEWTON, Mass., April 26, 2021 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, …

Category:  Cancer Go Health

Karyopharm Announces Publication of XPOVIO® (Selinexor) Phase …

WEBNEWTON, Mass., Nov. 12, 2020 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, …

Category:  Cancer Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Healthkart hk vitals hair

 › Genesis healthcare maryland locations

 › Organizational goals in healthcare

 › Partners in health care

 › Vantage healthcare monroe la

 › Honor health arrowhead office az

 › Iop services mental health

 › Human health and disease neet

 › Allied health solutions dme wv

 › Scripps health la jolla

Recently Searched

 › Fallbrook healthcare cholesterol test

 › Premier health emergency room appointment

 › Why digital health matters

 › East cape province health

 › Affinity health beneficiary nomination form

 › Downstream factors in healthcare

 › Byron clinic mental health

 › Current health minister of pakistan

 › Mental health costs per month

 › Telehealth medicaid plan w